High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 1049-1059

  Iyevleva, Aglaya G ^a,b   Kuligina, Ekatherina Sh ^a   Mitiushkina, Nathalia V ^a   Togo, Alexandr V ^a   Miki, Yoshio ^c   Imyanitov, Evgeny N ^a,b,d  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

^c CANCER INSTITUTE   (Japan)

^d St Petersburg Medical Academy for Postgraduate Studies   (Russian Federation)

Author keywords

Bilateral breast cancer; Breast cancer predisposition; microRNA

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 10B; MICRORNA 155; MICRORNA 17; MICRORNA 18A; MICRORNA 200C; MICRORNA 205; MICRORNA 21; MICRORNA 27A; MICRORNA 31; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BILATERAL BREAST CARCINOMA; BREAST CARCINOMA; CANCER INCIDENCE; CANCER INVASION; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; UNILATERAL BREAST CARCINOMA; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY;

EID: 84856213305     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1845-z     Document Type: Article

References (51)

1. EN Imyanitov KP Hanson 2003 Molecular pathogenesis of bilateral breast cancer Cancer Lett 191 1 7 12609703 10.1016/S0304-3835(02)00523-2 1:CAS:528:DC%2BD3sXhsVCmu78%3D
2. E Kuligina A Reiner EN Imyanitov CB Begg 2010 Evaluating cancer epidemiologic risk factors using multiple primary malignancies Epidemiology 21 366 372 20299982 10.1097/EDE.0b013e3181cc8871
3. Y Chen W Thompson R Semenciw Y Mao 1999 Epidemiology of contralateral breast cancer Cancer Epidemiol Biomarkers Prev 8 855 861 10548312 1:STN:280:DC%2BD3c%2FhsVenug%3D%3D
4. B Majed A Dozol L Ribassin-Majed K Senouci B Asselain 2011 Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association Breast Cancer Res Treat 126 729 738 20872242 10.1007/s10549-010-1153-z
5. EN Imyanitov EN Suspitsin MY Grigoriev AV Togo Kuligina ESh EV Belogubova KM Pozharisski EA Turkevich C Rodriquez CJ Cornelisse KP Hanson C Theillet 2002 Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas Int J Cancer 100 557 564 12124805 10.1002/ijc.10530 1:CAS:528:DC%2BD38Xlslyjsbk%3D
6. SC Park UK Hwang SH Ahn GY Gong HS Yoon 2007 Genetic changes in bilateral breast cancer by comparative genomic hybridisation Clin Exp Med 7 1 5 17380298 10.1007/s10238-007-0123-1 1:CAS:528:DC%2BD2sXjtlygtL4%3D
7. D Huo S Melkonian PJ Rathouz A Khramtsov OI Olopade 2011 Concordance in histological and biological parameters between first and second primary breast cancers Cancer 117 907 915 20945326 10.1002/cncr.25587
8. HG Russnes ESh Kuligina EN Suspitsin DA Voskresenskiy ES Jordanova CJ Cornelisse AL Borresen-Dale EN Imyanitov 2001 Paired distribution of molecular subtypes in bilateral breast carcinomas Cancer Genet 204 96 102 10.1016/j.cancergencyto.2010.09.012
9. EN Suspitsin AP Sokolenko AV Togo YR Lazareva EA Turkevich DE Matsko KO Henrich AL Borresen-Dale M Schwab CJ Cornelisse EN Imyanitov 2007 Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: possible role of host factors and survival bias Int J Cancer 120 297 302 17066426 10.1002/ijc.22265 1:CAS:528:DC%2BD28XhtlGqsrvP
10. SM Swain JW Wilson EP Mamounas J Bryant DL Wickerham B Fisher S Paik N Wolmark 2004 Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer J Natl Cancer Inst 96 516 523 15069113 10.1093/jnci/djh097 1:CAS:528:DC%2BD2cXjtVShtb4%3D
11. Kuligina ESh MY Grigoriev EN Suspitsin KG Buslov OA Zaitseva OS Yatsuk YR Lazareva AV Togo EN Imyanitov 2007 Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies J Cancer Res Clin Oncol 133 57 64
12. EN Suspitsin EU Due P Vu A Hirvonen AL Børresen-Dale EN Imyanitov 2008 TP53 mutations in synchronous and metachronous bilateral breast carcinomas Cancer Genet Cytogenet 184 119 121 18617062 10.1016/j.cancergencyto.2008.03.005 1:CAS:528:DC%2BD1cXosVygtbs%3D
13. J Le Quesne C Caldas 2010 Micro-RNAs and breast cancer Mol Oncol 4 230 241 20537965 10.1016/j.molonc.2010.04.009 1:CAS:528:DC%2BC3cXhtVGlsLvJ
14. E O'Day A Lal 2010 MicroRNAs and their target gene networks in breast cancer Breast Cancer Res 12 201 20346098 10.1186/bcr2484
15. GL Huang XH Zhang GL Guo KT Huang KY Yang X Shen J You XQ Hu 2009 Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma Oncol Rep 21 673 679 19212625 1:CAS:528:DC%2BD1MXjvVWhsbY%3D
16. T Li D Li J Sha P Sun Y Huang 2009 MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells Biochem Biophys Res Commun 383 280 285 19302977 10.1016/j.bbrc.2009.03.077 1:CAS:528:DC%2BD1MXlsVKjtrw%3D
17. B Song C Wang J Liu X Wang L Lv L Wei L Xie Y Zheng X Song 2010 MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression J Exp Clin Cancer Res 29 29 20346171 10.1186/1756-9966-29-29 1:CAS:528:DC%2BC3MXps1Ohsw%3D%3D
18. Schramedei K, Mörbt N, Pfeifer G, Läuter J, Rosolowski M, Tomm JM, von Bergen M, Horn F, Brocke-Heidrich K (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30:2975-2985
19. LX Yan QN Wu Y Zhang YY Li DZ Liao JH Hou J Fu MS Zeng JP Yun QL Wu YX Zeng JY Shao 2011 Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth Breast Cancer Res 13 R2 21219636 10.1186/bcr2803 1:CAS:528:DC%2BC3MXpt1aktw%3D%3D
20. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 682 688 17898713 10.1038/nature06174 1:CAS:528:DC%2BD2sXhtFChurfF
21. CH Moriarty B Pursell AM Mercurio 2010 miR-10b targets Tiam1: implications for Rac activation and carcinoma migration J Biol Chem 285 20541 20546 20444703 10.1074/jbc.M110.121012 1:CAS:528:DC%2BC3cXnvFSisbc%3D
22. IM Pedersen D Otero E Kao AV Miletic C Hother E Ralfkiaer RC Rickert K Gronbaek M David 2009 Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas EMBO Mol Med 1 288 295 19890474 10.1002/emmm. 200900028 1:CAS:528:DC%2BD1MXht1CjurvN
23. S Jiang HW Zhang MH Lu XH He Y Li H Gu MF Liu ED Wang 2010 MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res 70 3119 3127 20354188 10.1158/0008-5472.CAN-09-4250 1:CAS:528:DC%2BC3cXkslShtrw%3D
24. W Kong L He M Coppola J Guo NN Esposito D Coppola JQ Cheng 2010 MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer J Biol Chem 285 17869 17879 20371610 10.1074/jbc.M110.101055 1:CAS:528:DC%2BC3cXmslSmsb4%3D
25. D Rai SW Kim MR McKeller PL Dahia RC Aguiar 2010 Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis Proc Natl Acad Sci USA 107 3111 3116 20133617 10.1073/pnas.0910667107 1:CAS:528:DC%2BC3cXis1Clu78%3D
26. F Wang Z Zheng J Guo X Ding 2010 Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor Gynecol Oncol 119 586 593 20801493 10.1016/j.ygyno.2010.07.021 1:CAS:528: DC%2BC3cXhtlyrtbvM
27. P Wang J Hou L Lin C Wang X Liu D Li F Ma Z Wang X Cao 2010 Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1 J Immunol 185 6226 6233 20937844 10.4049/jimmunol.1000491 1:CAS:528:DC%2BC3cXhtlOhsbnO
28. SU Mertens-Talcott S Chintharlapalli X Li S Safe 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells Cancer Res 67 11001 11011 18006846 10.1158/0008-5472.CAN-07-2416 1:CAS:528:DC%2BD2sXhtlSlsLrL
29. IK Guttilla BA White 2009 Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells J Biol Chem 284 23204 23216 19574223 10.1074/jbc.M109.031427 1:CAS:528:DC%2BD1MXhtVWqtrnJ
30. T Liu H Tang Y Lang M Liu X Li 2009 MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin Cancer Lett 273 233 242 18789835 10.1016/j.canlet.2008.08.003 1:CAS:528:DC%2BD1cXhsV2gtbrF
31. X Li SU Mertens-Talcott S Zhang K Kim J Ball S Safe 2010 MicroRNA-27a indirectly regulates estrogen receptor alpha expression and hormone responsiveness in MCF-7 breast cancer cells Endocrinology 151 2462 2473 20382698 10.1210/en.2009-1150 1:CAS:528:DC%2BC3cXnsVyqsbs%3D
32. Y Ma S Yu W Zhao Z Lu J Chen 2010 miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 Cancer Lett 298 150 158 20638779 10.1016/j.canlet.2010.06.012 1:CAS:528: DC%2BC3cXhtlSgt7nK
33. O Aprelikova X Yu J Palla BR Wei S John M Yi R Stephens RM Simpson JI Risinger A Jazaeri J Niederhuber 2010 The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts Cell Cycle 9 4387 4398 20980827 10.4161/cc.9.21.13674 1:CAS:528:DC%2BC3MXit1Kktbc%3D
34. DR Cochrane NS Spoelstra EN Howe SK Nordeen JK Richer 2009 MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents Mol Cancer Ther 8 1055 1066 19435871 10.1158/1535-7163.MCT-08-1046 1:CAS:528:DC%2BD1MXmtlGqsLo%3D
35. Y Shimono M Zabala RW Cho N Lobo P Dalerba D Qian M Diehn H Liu SP Panula E Chiao FM Dirbas G Somlo RA Pera K Lao MF Clarke 2009 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 592 603 19665978 10.1016/j.cell.2009.07.011 1:CAS:528:DC%2BD1MXhsVChs7bP
36. R Schickel SM Park AE Murmann ME Peter 2010 miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1 Mol Cell 38 908 915 20620960 10.1016/j.molcel.2010.05.018 1:CAS:528:DC%2BC3cXovVWmur4%3D
37. C Blenkiron LD Goldstein NP Thorne I Spiteri SF Chin MJ Dunning NL Barbosa-Morais AE Teschendorff AR Green IO Ellis S Tavaré C Caldas EA Miska 2007 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biol 8 R214 17922911 10.1186/gb-2007-8-10-r214
38. L Castellano G Giamas J Jacob RC Coombes W Lucchesi P Thiruchelvam G Barton LR Jiao R Wait J Waxman GJ Hannon J Stebbing 2009 The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response Proc Natl Acad Sci USA 106 15732 15737 19706389 10.1073/pnas.0906947106 1:CAS:528:DC%2BD1MXhtFyjsLnL
39. SK Leivonen R Mäkelä P Ostling P Kohonen S Haapa-Paananen K Kleivi E Enerly A Aakula K Hellström N Sahlberg VN Kristensen AL Børresen-Dale P Saviranta M Perälä O Kallioniemi 2009 Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines Oncogene 28 3926 3936 19684618 10.1038/onc.2009.241 1:CAS:528:DC%2BD1MXpvFCrtL4%3D
40. PA Gregory AG Bert EL Paterson SC Barry A Tsykin G Farshid MA Vadas Y Khew-Goodall GJ Goodall 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 593 601 18376396 10.1038/ncb1722 1:CAS:528:DC%2BD1cXltl2is7c%3D
41. MV Iorio P Casalini C Piovan G Di Leva A Merlo T Triulzi S Ménard CM Croce E Tagliabue 2009 microRNA-205 regulates HER3 in human breast cancer Cancer Res 69 2195 2200 19276373 10.1158/0008-5472.CAN-08-2920 1:CAS:528:DC%2BD1MXjtFyqt78%3D
42. H Wu S Zhu YY Mo 2009 Suppression of cell growth and invasion by miR-205 in breast cancer Cell Res 19 439 448 19238171 10.1038/cr.2009.18 1:CAS:528:DC%2BD1MXktVSltro%3D
43. H Li C Bian L Liao J Li RC Zhao 2011 miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1 Breast Cancer Res Treat 126 565 575 20505989 10.1007/s10549-010-0954-4 1:CAS:528: DC%2BC3MXjt1Ghsbw%3D
44. Z Yu NE Willmarth J Zhou S Katiyar M Wang Y Liu PA McCue AA Quong MP Lisanti RG Pestell 2010 microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling Proc Natl Acad Sci USA 107 8231 8236 20406904 10.1073/pnas.1002080107 1:CAS:528:DC%2BC3cXmtVKgtro%3D
45. Imyanitov EN, Suspitsin EN, Buslov KG, Kuligina ESh, Belogubova EV, Togo AV, Hanson KP (2006) Isolation of nucleic acids from paraffin-embedded archival tissues and other difficult sources. In: Kieleczawa J (ed) DNA sequencing II: optimizing preparation and cleanup. Jones and Bartlett Publishers, Sudbury, pp 85-97
46. C Chen DA Ridzon AJ Broomer Z Zhou DH Lee JT Nguyen M Barbisin NL Xu VR Mahuvakar MR Andersen KQ Lao KJ Livak KJ Guegler 2005 Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res 33 e179 16314309 10.1093/nar/gni178
47. HJ Peltier GJ Latham 2008 Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues RNA 14 844 852 18375788 10.1261/rna.939908 1:CAS:528:DC%2BD1cXls1Wrtr0%3D
48. M Aickin H Gensler 1996 Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods Am J Public Health 86 726 728 8629727 10.2105/AJPH.86.5.726 1:STN:280:DyaK283ht1eksg%3D%3D
49. AP Sokolenko ME Rozanov NV Mitiushkina NY Sherina AG Iyevleva EV Chekmariova KG Buslov ES Shilov AV Togo EM Bit-Sava DA Voskresenskiy OL Chagunava P Devilee C Cornelisse VF Semiglazov EN Imyanitov 2007 Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia Fam Cancer 6 281 286 17333477 10.1007/s10689-007-9120-5 1:CAS:528:DC%2BD2sXot12lsbg%3D
50. AG Iyevleva EN Suspitsin K Kroeze TV Gorodnova AP Sokolenko KG Buslov DA Voskresenskiy AV Togo SP Kovalenko N Stoep P Devilee EN Imyanitov 2010 Non-founder BRCA1 mutations in Russian breast cancer patients Cancer Lett 298 258 263 20727672 10.1016/j.canlet.2010.07.013 1:CAS:528:DC%2BC3cXhtlSgtL7P
51. EN Imyanitov VM Moiseyenko 2011 Drug therapy for hereditary cancers Hered Cancer Clin Pract 9 5 21819606 10.1186/1897-4287-9-5 1:CAS:528: DC%2BC3MXht1Wrt7vK